Company intelligence / Profile preview

Concure Oncology

Mercer Island, Washington, United Statesconcureoncology.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

The company’s Breast Microseed Treatment delivers targeted radiation via permanent implantation of radioactive palladium seeds after lumpectomy for early-stage breast cancer. This approach aims to reduce recurrence by irradiating residual cancer cells locally with a single procedure. The treatment has been available clinically since at least 2016 and offers an alternative to traditional external beam radiation therapy.[1][5] No large-scale published clinical trial results are referenced in the provided sources.

Therapeutic areas: Oncology
Modalities: Device (specifically brachytherapy device)Radiopharmaceutical (radioactive palladium seeds)Non-pharmacological therapy (procedure-based)
Industry: Biotech

Beyond the preview

Go deeper on Concure Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concure Oncology.

Explore the full profile